Evaxion Biotech
Evaxion Biotech A/S is a clinical-stage AI-immunology™ platform company decoding the human immune system to discover and develop novel immunotherapies to treat cancer and infectious diseases.
Evaxion Biotech has raised €38M across 1 funding round from 1 investor, most recently a round in Jun 2022. Based in Copenhagen, Denmark; active in Healthtech. Data as of 28 Oct 2026.
Copenhagen, Denmarkwww.evaxion-biotech.com ↗
Total raised
€38M
€37,814,332
Funding rounds
1
Investors
1
distinct backers
Active since
2022-06
latest 2022-06
Funding by year
EUR raised per yearEvaxion Biotech — funding by year — interactive chart.
Data table
| Evaxion Biotech — funding by year | |
|---|---|
| 2022 | €38M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-06-10 | Other | €38M | Lincoln Park Capital Fund | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Oura Health€779MFinland · Healthtech
Global coverage: FundingData